Vitaflo

Vitaflo develops and markets specialized medical foods for dietary management of rare inherited metabolic diseases, pediatric kidney conditions, and conditions requiring a ketogenic diet. Their products are clinically validated and available in over 70 countries. No traditional clinical trial results as with pharmaceuticals; efficacy demonstrated through nutritional studies supporting dietary compliance and improved patient outcomes. The company has a strong reputation among healthcare professionals for evidence-based innovation in medical nutrition. Not applicable—Vitaflo operates on a portfolio model of commercialized specialized nutrition products rather than a pharmaceutical-style R&D pipeline. However, they continuously develop new formulations/products within their focus areas.